Strategic Analysis of Anti-obesity Prescription Drug Development

Recent Marketing Approvals Revive Hope for Successful Treatment Options

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timelines, regulatory guidelines for clinical trial design and approval, and global epidemiology by region.

Table of Contents

Strategic Analysis of Anti-obesity Prescription Drug Development Analysis of the Anti-obesity Prescription Pharmaceuticals PipelineExecutive SummaryMethodology and ScopeIntroductionCompetitive LandscapeConclusions and RecommendationsAppendixThe Frost & Sullivan Story




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.